Nucleic acid amplification testing (NAAT) is increasingly being adopted for diagnosis of Clostridium difficile infection (CDI). Data from 3 states conducting population-based CDI surveillance showed increases ranging from 43% to 67% in CDI incidence attributable to changing from toxin enzyme immunoassays to NAAT. CDI surveillance requires adjustment for testing methods.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580544 | PMC |
| http://dx.doi.org/10.1093/cid/cit492 | DOI Listing |
Publication Analysis
Top Keywords
nucleic acid
8
acid amplification
8
amplification testing
8
clostridium difficile
8
difficile infection
8
cdi surveillance
8
testing population-based
4
population-based incidence
4
incidence rates
4
rates clostridium
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!